Login / Signup

Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis.

Jesko MomotowIna BühnenKarolin Trautmann-GrillGuido KobbeDennis HahnRoland SchroersBernhard HeinrichTobias GaskaHelmut ForstbauerBurkhard SchmidtRegina BogerAndreas HuettmannGerhard HeilDoris M KraemerWilliam KrügerVanja ZeremskiNorbert GrobeKathleen Jentsch-UllrichFrank GriesingerMichael FuchsBastian von TresckowPeter BorchmannAndreas EngertPaul J Bröckelmann
Published in: British journal of haematology (2022)
Keyphrases
  • hodgkin lymphoma
  • clinical trial
  • type diabetes
  • cross sectional
  • acute myeloid leukemia
  • metabolic syndrome
  • acute lymphoblastic leukemia
  • multiple myeloma
  • skeletal muscle